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Abstract
Background: It is widely accepted that vulvar carcinoma with a depth of invasion of less than one
millimeter is sufficiently treated by vulvectomy or wide local excision without inguinal
lymphadenectomy.
Case presentation: However, a patient with inguinal lymph node recurrence 21 months after
radical vulvectomy for stage IA squamous cell carcinoma was observed.
Conclusion:  According to a review of the literature, there are five additional cases of
metastasizing vulvar cancer with a depth of invasion of less than one millimeter. Therefore, the
definition of microinvasive carcinoma of the vulva based on depth of invasion alone may not be as
reliable as previously thought and does not rule out inguinal lymph node involvement or
recurrence. Consequently, the necessity of inguinal node dissection for microinvasive carcinoma
needs to be discussed on an individual basis taking into account the age of the patient as well as the
potential morbidity of extended surgery.
Background
Invasive vulvar carcinoma of all stages is usually treated by
radical vulvectomy and bilateral lymphadenectomy.
However, such an extensive surgical procedure has a high
morbidity. In younger women, severe psychologic stress is
caused by this hugely deforming operation, as sexual
function and body image are disturbed. Therefore, over
the past twenty years, efforts have been made to individu-
alize treatment and to define a subgroup of patients which
may be treated by less radical procedures [1]. It is widely
thought that tumors with a depth of invasion of less than
one millimeter according to criteria established by Wilkin-
son et al. [2,3] are sufficiently treated by vulvectomy or
wide local excision without lymphadenectomy. However,
there are five reports of lymph node metastases in patients
with so-called "microinvasive carcinoma of the vulva". The
patient reported here also developed inguinal lymph
node metastasis after local treatment for squamous cell
carcinoma of the vulva with a depth of invasion of less
than one millimeter.
Case presentation
An 80-year-old white female was referred for evaluation of
a suspicious vulvar lesion in September of 1997. At that
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time, the patient was free of complaints. On physical
exam, atrophy of the vulva was seen but without evidence
of lichen sclerosus. Approximately five millimeters from
the clitoris, on the inner aspect of the left labium majus, a
1.5 cm indurated exophytic lesion was noted bleeding on
touch (Figure 1). There was no involvement of the urethra
or vagina. No regional lymphadenopathy was noted at
this time. Biopsy revealed keratinizing squamous cell car-
cinoma. The patient had a previous history of recurrent
adenocarcinoma within the oral cavity but had been free
of disease for ten years.
Anterior radical vulvectomy without inguinal lymph node
dissection was performed with margins of at least 2 cm
from the well defined lesion. Frozen section biopsy
revealed a depth of invasion of less than 1 mm. His-
topathologic evaluation of the entire specimen showed a
well differentiated 1.7 × 1.5 cm superficially invasive
keratinizing squamous cell carcinoma (Figure 2). The exo-
phytic tumor had a thickness of 5 mm. The greatest depth
of invasion was 0.08 mm using the criteria established by
Wilkinson et al. [2]. No lymphvascular space involvement
was seen and margins were tumor-free (at least 7 mm at
the urethral margin as measured on the paraffin-embed-
ded specimen).
The patient remained free of disease until twenty-one
months later when she noticed a painful swelling of the
left inguinal area (Figure 3). A five centimeter tumor was
noted. A CT scan of the abdomen and pelvis did not show
any enlarged pelvic or paraaortic lymph nodes. Subse-
quently, bilateral inguinal lymphadenectomy was per-
formed. The left inguinal tumor was found to be a 4.3 cm
metastasis of a well to moderately differentiated keratiniz-
ing squamous cell carcinoma consistent with the previous
diagnosis of vulvar carcinoma (Figure 4). At that time,
there was no evidence of vulvar recurrence and radiation
therapy was given to the groin and to the pelvis. The
patient remained free of disease for 69 months. She then
developed extensive vulvar recurrence and was treated
with palliative radiation therapy. She died 8 months later.
Conclusion
So far, five cases of regional lymph node recurrences fol-
lowing treatment for FIGO stage Ia squamous cell carci-
noma of the vulva have been reported in the literature [4-
8]. One of two cases described by Thangavelu et al [5] can-
not be considered true stage IA disease as the tumor was
multifocal at initial presentation, the official FIGO classi-
fication stating that "Stage IA carcinoma of the vulva is
defined as a single lesion measuring 2 cm or less in diam-
eter with a depth of invasion of 1.0 mm or less ..." [9].
Age at initial diagnosis was between 39 and 84 years.
Tumors were well differentiated (G1) in three patients
[4,7,8] including the present case. None of the tumors
showed lymphvascular space involvement. In four
patients, vulvar intraepithelial neoplasia (VIN) was also
present [4-6]. All patients with the exception of the case
presented here had had a long-standing history of local
complaints such as pruritus or suffered from vulvar dis-
eases such as lichen sclerosus prior to the diagnosis of vul-
var cancer.
The case reported by Volgger et al [4] is unusual as the
patient had received immunosuppressive treatment for
twelve years following a renal transplant. Long-standing
Immunosuppression may have influenced the course of
disease leading to groin node recurrence which occurred
only four months after initial diagnosis, whereas, in the
other five cases of microinvasive carcinoma, recurrence
free survival was reported between 12 and 36 months.
All inguinal recurrences were unilateral. Five patients [4-
6] including the present case died from progressive dis-
ease and/or distant metastases. In the other two cases
[7,8], no follow-up information was provided.
In summary, no pattern of particular risk factors can be
deducted from this small number of cases. Theoretically,
HPV status of the tumor tissue may play a role. However,
Pinto et al [10] did not find an association between HPV
DNA in the primary tumor and clinical outome in
patients with vulvar carcinoma, whereas viral presence in
the inguinal lymph node metastases was indeed associ-
ated with a worse prognosis.
As the salvage rate for patients with inguinal recurrence is
low, the development of groin metastases might have
been avoided in some of these patients if inguinal lym-
phadenectomy had been performed at the time of initial
Microinvasive squamous cell carcinoma of the vulva Figure 1
Microinvasive squamous cell carcinoma of the vulva. 
Initial presentation. Surgical resection margins are marked.BMC Cancer 2006, 6:157 http://www.biomedcentral.com/1471-2407/6/157
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cancer diagnosis [11]. In retrospect, the patient discussed in this article had been brought into remission through
secondary lymph node dissection and radiation therapy.
At the time of recurrence she was already 82 years old. In
a younger patient, radiation therapy with the concurrent
administration of cytotoxic treatment using cisplatin
should have been considered.
A more extensive surgical approach including pelvic lym-
phadenectomy should be reserved for the debulking of
grossly positive nodes. In all other cases the routine
removal of pelvic lymph nodes is obsolete [12].
In conclusion, the definition of microinvasive carcinoma
of the vulva based on depth of invasion alone is not as
reliable as previously thought for ruling out inguinal
lymph node involvement or recurrence. Although the
present standard of care cannot be revised on the basis of
a very small number of cases, the necessity of inguinal sur-
Inguinal lymph node recurrence 21 months after treatment  for microinvasive vulvar carcinoma Figure 3
Inguinal lymph node recurrence 21 months after 
treatment for microinvasive vulvar carcinoma. Swell-
ing of the left groin. Resection margins are outlined.
Photomicrograph of microinvasive squamous cell carcinoma of the vulva Figure 2
Photomicrograph of microinvasive squamous cell carcinoma of the vulva.BMC Cancer 2006, 6:157 http://www.biomedcentral.com/1471-2407/6/157
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gery for microinvasive carcinoma needs to be discussed
on an individual basis taking into account the age of the
patient as well as the potential morbidity. In addition,
immunocompromised patients may be at a significantly
higher risk for inguinal spread of vulvar cancer.
Thus, unilateral inguinal lymph node dissection through
a separate incision should not be ruled out entirely in
patients with microinvasive vulvar cancer. Certainly, radi-
cal groin node dissection with removal of the fascia lata
and resection of the saphenous vein is not justified.
Instead, the surgical procedure should be tailored to the
exact localization of inguinal lymph nodes as defined by
several anatomical studies [13-15].
Nevertheless, lymph node involvement is rare if depth of
invasion is less than one millimeter, and omission of
inguinal lymph node dissection may be discussed individ-
ually with selected patients in order to avoid the consider-
able morbidity following inguinal surgery. In the future,
these patients should undergo sentinel lymph node
biopsy. Although not yet applied routinely in vulvar can-
Inguinal lymph node recurrence 21 months after treatment for microinvasive vulvar carcinoma Figure 4
Inguinal lymph node recurrence 21 months after treatment for microinvasive vulvar carcinoma. The surgical 
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cer patients, preliminary studies show its feasibility: Sliutz
et al [16] have been able to identify one or more sentinel
lymph nodes in all 26 patients studied. Furthermore, the
survival of patients with early vulvar cancer treated with
sentinel lymph node biopsy and radical local excision
appears to be excellent [17].
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